MedTrace Logo

Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate

NCT00585962 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2017-09-05

No results posted yet for this study

Summary

The primary purpose of this study is to determine if high doses of radiation using proton beam can be given safely with low and acceptable side effects. This study will also gather data to determine the ability of the proton beam to eradicate prostate cancer. Proton beam radiation is a very accurate kind of treatment that has been shown to affect less normal tissue than a regular radiation beam.

Conditions

Interventions

RADIATION

Proton Beam Radiation

Once a day, 5 days a week (Monday-Friday), for 8 weeks.

Sponsors & Collaborators

  • American College of Radiology Imaging Network

    collaborator NETWORK

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Anthony Zietman, MD · Massachusetts General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00585962 on ClinicalTrials.gov